Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950138-05-000145
Filing Date
2005-02-14
Accepted
2005-02-14 13:51:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 ROTH-STARK\2005\FEB 13GAS\FEB 13GA-ALFACELL feb13ga-alfacell.txt SC 13G/A 12213
  Complete submission text file 0000950138-05-000145.txt   14072
Mailing Address 225 BELLEVILLE AVE 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
ALFACELL CORP (Subject) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 0731
Type: SC 13G/A | Act: 34 | File No.: 005-45493 | Film No.: 05606947
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 4142411810
ROTH MICHAEL (Filed by) CIK: 0001010207 (see all company filings)

Type: SC 13G/A